Mochida Pharmaceutical Co., Ltd.

Shinichi Oikawa

Yasushi Saito

Yuji Matsuzawa

Masunori Matsuzaki

Hideki Origasa

Mitsuhiro Yokoyama

Yuichi Ishikawa

Hiroshige Itakura

Toru Kita

Hitoshi Hishida

Kunio Shirato

Kazuyuki Shimada

Toshiie Sakata

Noriaki Nakaya

Akira Kitabatake

Jun Sasaki

Masahiko Ohta

A medical composition for reducing the rate of new-onset diabetes caused by administration of a statin or for inhibiting an increase in blood glucose level by administration of a statin, the composition containing at least one ingredient selected from the group consisting of icosapentaenoic acid and pharmaceutically acceptable salts or esters thereof as an inactive ingredient.

Composition for reducing new-onset diabetes

Provided are composition and/or methods useful in preventing onset and/or recurrence of cardiovascular events, especially in patients who have escaped the unstable period after cardiovascular angioplasty or in hyperlipidemia patients who have been treated with HMG-CoA RI.

Composition and/or method for preventing onset and/or recurrence of cardiovascular events

Growing community of inventors

Tokyo, Japan

Shinichi Oikawa